EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Blockchain-Enabled Traceability in Pharmaceutical Supply Chains: A Mapping Review of Evidence for Visibility, Anti-Counterfeiting, and Chain-of-Custody Control

Félix Díaz, Nhell Cerna, Rafael Liza, Bryan Motta, Segundo Rojas-Flores

Logistics · 10.04.2026 · 10 (4) · 85

DOI: 10.3390/logistics10040085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Logistics, online erschienen am 10.04.2026. Verfasst von Félix Díaz und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Blockchain is increasingly proposed to strengthen pharmaceutical traceability, anti-counterfeiting, and chain of custody in multi-actor supply chains, but the evidence base remains heterogeneous in technical rigor and operational clarity.

Methods

We conducted a mapping review of Scopus and Web of Science to map publication patterns, identify dominant thematic configurations, and compare citation-salient studies across recurring solution profiles and operational design dimensions. The final corpus comprised 103 records.

Results

The literature expanded rapidly from 2019 to 2025, with notable geographic concentration and dissemination mainly through technically focused outlets. Keyword analysis identified a core traceability theme, an implementation stream centered on smart contracts, Ethereum, and security, and additional streams involving vaccines and regulatory or credentialing concerns. Citation-salient studies clustered into implemented systems and prototypes, architecture or framework proposals, and contextual maturity or decision-layer evidence. Across these profiles, transferability depended less on platform choice than on governance and access-control assumptions, modular smart contract roles, and verifiable on-chain/off-chain data placement.

Conclusions

Chain-of-custody semantics and evaluation methods remain inconsistently formalized, limiting cross-study comparability and the interpretability of operational claims. Benchmark-oriented assessments and minimal reporting standards specifying governance parameters, logistics scope and checkpoints, workload, measurement conditions, and concrete evidence artifacts are needed.

Zitieren

APA

Díaz, F., Cerna, N., Liza, R., Motta, B., & Rojas-Flores, S. (2026). Blockchain-Enabled Traceability in Pharmaceutical Supply Chains: A Mapping Review of Evidence for Visibility, Anti-Counterfeiting, and Chain-of-Custody Control. Logistics, 10(4), 85. https://doi.org/10.3390/logistics10040085

Vancouver

Díaz F, Cerna N, Liza R, Motta B, Rojas-Flores S. Blockchain-Enabled Traceability in Pharmaceutical Supply Chains: A Mapping Review of Evidence for Visibility, Anti-Counterfeiting, and Chain-of-Custody Control. Logistics. 2026;10(4):85. doi:10.3390/logistics10040085

BibTeX
@article{Daz2026,
  author = {Díaz, Félix and Cerna, Nhell and Liza, Rafael and Motta, Bryan and Rojas-Flores, Segundo},
  title = {Blockchain-Enabled Traceability in Pharmaceutical Supply Chains: A Mapping Review of Evidence for Visibility, Anti-Counterfeiting, and Chain-of-Custody Control},
  journal = {Logistics},
  year = {2026},
  volume = {10},
  number = {4},
  pages = {85},
  doi = {10.3390/logistics10040085}
}
Kostenlos starten →